SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-022632
Filing Date
2024-02-29
Accepted
2024-02-29 07:00:14
Documents
16
Period of Report
2024-02-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ka-20240229.htm   iXBRL 8-K 74834
2 EX-10.1 ka-ex10_1.htm EX-10.1 58784
3 EX-10.2 ka-ex10_2.htm EX-10.2 59309
4 EX-99.1 ka-ex99_1.htm EX-99.1 17919
5 GRAPHIC img94373455_0.jpg GRAPHIC 40842
  Complete submission text file 0000950170-24-022632.txt   420840

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ka-20240229.xsd EX-101.SCH 30881
18 EXTRACTED XBRL INSTANCE DOCUMENT ka-20240229_htm.xml XML 4695
Mailing Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98109
Business Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98109 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 24698773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)